From a clinical perspective, the diuretic action of SGLT2 inhibitors must be taken into consideration when prescribing this drug class, particularly in patients already on diuretics for hypertension, heart failure or chronic kidney disease. This evidence concerns the gene SLC5A2 and Hypertension.